Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action
Crossref DOI link: https://doi.org/10.1186/s12943-015-0468-0
Published Online: 2015-11-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bartscht, Tobias
Rosien, Benjamin
Rades, Dirk
Kaufmann, Roland
Biersack, Harald
Lehnert, Hendrik
Gieseler, Frank
Ungefroren, Hendrik